Sugi Predict

Sugi Predict / Compounds / SCHEMBL165357

SCHEMBL165357

SCHEMBL165357

CC=Cc1cccc(C(=O)O)c1

nearest known ligand 0.64

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ TTR P02766 5/20 0.64
▸ UNG P13051 1/20 0.63
▸ FBP1 P09467 1/20 0.60
▸ P4HB P07237 3/20 0.57
▸ CA12 O43570 1/20 0.48
▸ CA1 P00915 1/20 0.48
▸ CA2 P00918 1/20 0.48
▸ CA6 P23280 1/20 0.48
▸ CA9 Q16790 1/20 0.48
▸ KMO O15229 1/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ CYP2C9 P11712 1/20 0.46
▸ HPGD P15428 1/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ PPARG P37231 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11691933 1.00 TTR (0.64) TTRUNGFBP1P4HBCA12
SCHEMBL13711686 1.00 TTR (0.64) TTRUNGFBP1P4HBCA12
SCHEMBL808972 0.88 TTR (0.79) TTRUNGFBP1P4HBCA12
SCHEMBL808971 0.88 TTR (0.79) TTRUNGFBP1P4HBCA12
SCHEMBL9075299 0.88 TTR (0.79) TTRUNGFBP1P4HBCA12
SCHEMBL8899992 0.88 TTR (0.79) TTRUNGFBP1P4HBCA12
SCHEMBL9497127 0.85 ATM (0.59) TTRUNGHPGDHSD17B10
SCHEMBL9497132 0.85 ATM (0.59) TTRUNGHPGDHSD17B10
SCHEMBL27533096 0.85 TTR (0.46) TTRUNGFBP1P4HB
SCHEMBL2954366 0.84 UNG (0.68) TTRUNGFBP1P4HBCA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104812789-B Fumaric diester-cinnamic acid ester copolymer, method for producing same, and film using same 东曹株式会社 2016-08-31 — — CN claimed
CN-110446977-B Blue photosensitive resin composition, color filter manufactured by using the same and image display device 东友精细化工有限公司 2023-11-14 — — CN disclosed
CN-115831604-A Metallized film for new energy automobile capacitor and preparation method thereof 河南华佳新材料技术有限公司 2023-03-21 — — CN disclosed
CN-110419002-B Photosensitive resin composition, color filter prepared using the same, and image display device 东友精细化工有限公司 2023-02-21 — — CN disclosed
CN-109844640-B Self-emission type photosensitive resin composition, color filter and image display device manufactured using the same 东友精细化工有限公司 2022-06-28 — — CN disclosed
CN-111320978-A Quantum dots and applications thereof 东友精细化工有限公司 2020-06-23 — — CN disclosed
US-10428343-B2 Modification of lignin biosynthesis via sense suppression DAIRY AUSTRALIA LIMITED (AU) 2019-10-01 — — US disclosed
CN-109265411-A 4- hydroxyl-3- substitution-thiazolidine -2 -one class compound preparation method 武汉轻工大学 2019-01-25 — — CN disclosed
US-20170191075-A1 Modification of Lignin Biosynthesis Via Sense Suppression DAIRY AUSTRALIA LIMITED (AU) 2017-07-06 — — US disclosed
US-9487517-B2 Spiroimidazolone derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2016-11-08 — — US disclosed
US-20080149175-A1 Organic dye, photoelectric conversion material, semiconductor electrode and photoelectric conversion device HORIUCHI TAMOTSU 2008-06-26 — — US disclosed
US-20080087327-A1 Organic dye, photoelectric conversion material, semiconductor electrode and photoelectric conversion device HORIUCHI TAMOTSU 2008-04-17 — — US disclosed
US-20080087327-A1 Organic dye, photoelectric conversion material, semiconductor electrode and photoelectric conversion device HORIUCHI TAMOTSU 2008-04-17 — — US disclosed
EP-0938471-B1 THE PREPARATION AND USE OF ORTHO-SULFONAMIDO ARYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE AND TACE INHIBITORS AMERICAN CYANAMID CO (US) 2001-12-12 — — EP disclosed
CN-1240429-A Preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors AMERICAN CYANAMID CO (US) 2000-01-05 — — CN disclosed
EP-0938471-A1 THE PREPARATION AND USE OF ORTHO-SULFONAMIDO ARYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE AND TACE INHIBITORS American Cyanamid Company (US) 1999-09-01 — — EP disclosed
US-5929097-A INHIBIT TUMOR NECROSIS FACTOR-ALPHA CONVERTING ENZYME AMERICAN CYANAMID COMPANY (US) 1999-07-27 — — US disclosed
WO-1998016503-A2 THE PREPARATION AND USE OF ORTHO-SULFONAMIDO ARYL HYDROXAMIC ACIDS AS MATRIX METALLOPROTEINASE AND TACE INHIBITORS AMERICAN CYANAMID COMPANY (US) 1998-04-23 — — WO disclosed
US-4350638-A ANTIMALARIAL AGENTS RESEARCH CORPORATION (US) 1982-09-21 — — US disclosed
US-4044049-A Phenyl benzoic acid compounds MERCK & CO., INC. (US) 1977-08-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080149175-A1 Organic dye, photoelectric conversion material, semiconductor electrode and photoelectric conversion device FTO, PPOX, CDH1 TTR 395/4885UNG 760/4885FBP1 4610/4885
US-20080087327-A1 Organic dye, photoelectric conversion material, semiconductor electrode and photoelectric conversion device FTO, PPOX, CDH1 TTR 395/4885UNG 760/4885FBP1 4610/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.